Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Adding Bevacizumab to the Treatment of Patients With Non-Small-Cell Lung Cancer: Caveat Emptor.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Adding Bevacizumab to the Treatment of Patients With Non-Small-Cell Lung Cancer: Caveat Emptor.
Adding Bevacizumab to the Treatment of Patients With Non-Small-Cell Lung Cancer: Caveat Emptor. J Oncol Pract. 2015 Sep; 11(5):363-4.
View in:
PubMed
subject areas
Angiogenesis Inhibitors
Bevacizumab
Carcinoma, Non-Small-Cell Lung
Female
Humans
Lung Neoplasms
Male
authors with profiles
Charles Lee Bennett
William J.M. Hrushesky